Antarctic ice shelves vulnerable to sudden meltwater-driven fracturing, says study

A new study says that many of the ice shelves ringing Antarctica could be vulnerable to quick destruction if rising temperatures drive melt water into the numerous fractures that currently penetrate their surfaces. The shelves help slow interior glaciers’ slide toward the ocean, so if they were to fail, sea levels around the world could surge rapidly as a result. The study appears this week in the leading journal Nature.

Ice shelves are giant tongues of ice floating on the ocean around the edges of the continent. The vast land-bound glaciers behind them are constantly pushing seaward. But because many shelves are largely confined within expansive bays and gulfs, they are compressed from the sides and slow the glaciers’ march — somewhat like a person in a narrow hallway bracing their arms against the walls to slow someone trying to push past them. But ice shelves experience a competing stress: they stretch out as they approach the ocean. Satellite observations show that, as a result, they rip apart; most are raked with numerous long fractures perpendicular to the direction of stretching. Fractures that form at the surface can be tens of meters deep; others, forming from the bottom, can penetrate the ice hundreds of meters upward. Some fractures are hundreds of meters wide.

Currently, most of the shelves are frozen year round, and stable. But scientists project that widespread warming could occur later in the century. And, existing research has shown that even subtle temperature swings can spur widespread melting. This could send melt water surging into the surface fractures. Such surges would potentially cause hydrofracturing-a process in which liquid water, heavier than ice, would violently force the fractures to zip open, and cause the shelf to rapidly disintegrate The new study estimates that 50 to 70 percent of the areas of the ice shelves buttressing the glaciers are vulnerable to such processes.

“It’s not just about melting, but where it’s melting,” said lead author Ching-Yao Lai, a postdoctoral researcher at Columbia University’s Lamont-Doherty Earth Observatory.

“The ice shelves-that’s the weak spot, where the atmosphere, the ice and ocean interact,” said study coauthor Jonathan Kingslake, a glaciologist at Lamont-Doherty. “If they fill up with melt water, things can happen very quickly after that, and there could be major consequences for sea levels.”

Hydrofracturing has already occurred in a few places. Parts of the Larsen Ice Shelf, which had been stable for at least 10,000 years, disintegrated within just days in 1995 and 2002. This was followed by the partial breakup of the Wilkins Ice Shelf in 2008 and 2009. The main agreed-upon causes: hydrofracturing. The Larsen and Wilkins comprise some of the northernmost ice on the continent, and so have been the first to suffer under rising temperatures and seasonal melting.

The new study follows a 2017 paper led by Kingslake showing that seasonal ponds and streams on the ice surface are far more common across Antarctica than previously believed; some reach within 375 miles of the South Pole. But most cataloged features are in places not subject to hydrofracturing. The new study shows that, so far, only about 0.6 percent of East Antarctic ice shelves that provide buttressing experience melt-water ponding, making them vulnerable. A much larger percentage would potentially be endangered, if warming takes hold.

In collaboration with Cameron Chen, a researcher from Google, Lai trained a machine-learning model to identify ice-shelf fracture locations across Antarctica, to produce the first continent-wide map of such features. Although most fractures now contain no liquid water, the scientists considered future cases in which melt water might fully fill the surface fractures. This allowed them to predict which parts of the shelves would be vulnerable to hydrofracturing, when factoring in the competing forces of compression from the sides, and stretching of the ice from back to front.

They calculated that inflow of liquid into the existing fractures could potentially exert enough force to cause widespread hydrofracturing across 50 to 70 percent of the ice-shelf areas that provide buttressing. The main exceptions were smaller, solider areas of ice closest to land, which experience less stress from stretching. The end portions of the shelves, mostly surrounded by open ocean, are also vulnerable, but floating freely as they do, those do not help hold back the glaciers.

While the study flashes a warning, the researchers say they cannot predict the ice shelves’ behavior with any exactitude. “How fast melt water would form and fill in those cracks is the first question,” said Kingslake. He said the worst-case scenario would be that “lots of places will be covered by lots and lots of water by the end of the century.” But projections vary widely, depending on which models scientists use, and how vigorously humanity cuts greenhouse gases, or not. The second question is whether particular locations will undergo hydrofracturing, he said. The third question: whether the process would run away, causing the shelf to undergo explosive Larsen-type disintegration.

Theodore Scambos, a leading Antarctic glaciologist and the National Snow and Ice Data Center, said the paper “does a great job of pointing to areas where one can say, ‘If it floods with melt here, it’s likely to break up the shelf.” He added that it “has huge implications for sea level” if summer temperatures along the coasts rise.

“Eventually, all the ice shelves could be covered by melt water,” said Lai. “But we don’t have a time frame, and there are a lot of big questions left.”

The study was also coauthored by Martin Wearing of the University of Edinburgh; Pierre Gentine, Harold Li and Julian Spergel of Columbia; and J. Melchior van Wessem of Utrecht University.

Share Button

Health24.com | More money, better heart health? Not always

Young people who pull themselves out of poverty may be no better off when it comes to their heart health, a new study suggests.

Researchers found that “upwardly mobile” US adults tended to be less stressed and depressed than peers who spent their whole lives below the poverty line. Unfortunately, it did not make a difference in their cardiovascular health.

They were just as likely to have conditions like obesity and elevated blood pressure, blood sugar and cholesterol, the study found.

The results might sound surprising, said Dr Nieca Goldberg, a cardiologist and volunteer expert with the American Heart Association. After all, both higher income and better mental health have been consistently linked with better physical health.

Better mental shape

“But I can think of a few reasons for the findings,” said Goldberg, who was not involved in the study.

“When you consider it, these are people who work very hard,” she said. “They may be really focused on their jobs, at the expense of other things. They may have no time for exercise, or end up eating a lot of grab-and-go foods.”

Compared with people whose income stays low, Goldberg said, they may be less worried about money and security – and, therefore, in better mental shape. But that doesn’t necessarily mean their lifestyles are healthy.

Lead researcher Gregory Miller agreed that lack of time for exercise or “restorative activities” like vacations could be a factor. But he also pointed to the “direct physical toll” of constant striving for the proverbial American dream.

Upwardly mobile Americans did show less psychological distress. But measures used in the study might not have picked up subtler issues, according to Miller, a faculty fellow at Northwestern University’s Institute for Policy Research in Evanston, Illinois.

“When you talk to people,” he said, “you hear things like, ‘I got to where I am due to great determination.’ And the attitude can be, ‘I don’t have time to be depressed, I don’t have time to be stressed. I have to keep going.'”

Signs of faster ageing

It can all start early, when a kid from a poor family “beats the odds” and gets into college, according to Miller. If earlier schooling left them less prepared, they may need to hit the books twice as hard as more-advantaged classmates.

The mindset of “I need to work twice as hard” can persist, especially for minorities facing racial discrimination, Miller said.

Other research has linked that type of striving to higher levels of stress hormones and signs of faster “ageing” in blood cells, according to Miller’s team.

The current findings are based on data from two US health studies begun in the 1990s. One involved a nationally representative sample of teens who were followed until their early 30s; the other included adults of all ages.

Participants were considered upwardly mobile if they grew up in families living below the poverty line or receiving welfare but their own incomes were higher.

Compared with their peers who remained in poverty, that group did report less “perceived stress” and depression symptoms, Miller’s team found. But they were just as likely to have metabolic syndrome – a collection of risk factors for heart disease that includes abdominal obesity, and elevated blood pressure, blood sugar and cholesterol.

‘Money can’t buy you health’

Overall, 29% of upwardly mobile Americans had metabolic syndrome by age 29, and 44% had developed it by middle-age. That compared with 24% and 33%, respectively, among people who were more advantaged throughout life.

The findings were published online in April in the Journal of the American Heart Association.

According to Goldberg, higher earnings may protect upwardly mobile people from some major stressors their parents faced – like worrying about paying the rent or affording groceries. “But money can’t buy you health,” she said.

Goldberg encouraged hard-working people to remember to care for themselves, too. That, she said, can be as simple as taking walks with your family.

Beyond that, Miller pointed to the need for broader efforts.

At colleges, for example, students from disadvantaged backgrounds can often get academic help if they need it; but, Miller said, “We don’t do much to help them feel more included.”

It can be isolating, he noted, “when you don’t have enough money for the football game, let alone the weekend ski trip.”

Image credit: iStock

Share Button

Health24.com | Could a hormone help spur high blood pressure?

Many people with high blood pressure may have an unrecognised hormonal condition driving their numbers up, a new study suggests.

The condition, called primary aldosteronism, arises when the adrenal glands overproduce the hormone aldosterone. That causes the body to retain sodium and lose potassium, spurring a spike in blood pressure.

Doctors have long considered the condition an uncommon cause of high blood pressure. But that, researchers say, is because they are simply not testing for it.

In the new study, about 22% of patients with more severe high blood pressure had primary aldosteronism. The same was true of almost 16% of patients with milder, stage 1 high blood pressure, according to findings published online in May in the Annals of Internal Medicine.

Common cause of hypertension

It all suggests doctors need to “redefine” the traditional view of primary aldosteronism, said researcher Dr Anand Vaidya, of Brigham and Women’s Hospital, in Boston.

Far from being rare, he said, it appears to be a common cause of high blood pressure.

The study is a “game-changer”, according to Dr John Funder, a distinguished scientist with the Hudson Institute of Medical Research, in Melbourne, Australia.

Funder said it shows that the way doctors have been screening for primary aldosteronism – for decades – does not provide the true story.

Funder, who wrote an editorial published with the findings, said the standard screening method is “fatally flawed”.

It is done via a single blood draw, taken in the morning. But aldosterone levels, like those of other hormones, fluctuate over the course of a day. So that single blood measurement, Funder explained, does not capture a person’s daily aldosterone secretion.

On top of the “misleading” test, he said, few people are screened at all.

Primary aldosteronism can be treated

Current guidelines suggest screening only in certain cases. That includes people who have “resistant” hypertension (the medical term for high blood pressure), which means blood pressure that remains high despite a three-medication regimen; and people with hypertension plus low potassium.

Yet even among those patients, only between 2% and 3% are ever screened, said Dr William F. Young Jr, chair of endocrinology at the Mayo Clinic in Rochester, Minnesota.

“Primary care providers don’t think about primary aldosteronism [PA] and do not test for it,” he said.

As an endocrinologist, Young generally sees patients only after their primary doctor refers them for specialist care.

“For more than three decades,” he said, “it has been frustrating to me to see patients who were not tested for PA when they were first diagnosed with hypertension, but rather only after they have developed irreversible, stage four to five chronic kidney disease.”

Varying degrees of hypertension

The good news is, primary aldosteronism can be treated. Most often, that means healthy lifestyle changes and taking aldosterone-blocking medications called mineralocorticoid receptor antagonists – which include spironolactone and eplerenone.

The new findings are based on 1 015 patients at four US hospitals. Some had normal blood pressure; the rest had varying degrees of hypertension. To screen for primary aldosterone, Vaidya’s team used a rigorous method: After some days on a high-sodium diet or sodium pills, patients collected their urine samples over 24 hours.

The researchers found that even among people with normal blood pressure, 11% had primary aldosteronism. That rate was 22% among people with resistant hypertension and those with stage 2 hypertension (blood pressure of at least 140/90 mm Hg).

But if someone with primary aldosteronism is already on blood pressure medication, isn’t that enough? No, Funder said.

He pointed to one 2018 study. It found that when patients with primary aldosteronism did not have the condition sufficiently controlled with medication, their risk of heart complications and death were three times higher, versus people with hypertension only.

Screening method ‘laborious’

Whether screening guidelines change remains to be seen. For now, Vaidya said that people with resistant hypertension should be screened (as already recommended), and that doctors “might consider it” for patients with more moderate hypertension.

An issue, though, is that the screening method used in this study is “laborious”, Vaidya noted. He said another option is to prescribe spironolactone for a period, to see if that lowers a patient’s blood pressure further. The drug has been around for years, and is available as a generic.

Funder was even more supportive of that tactic. “A three-month trial of spironolactone for patients with established hypertension is the way to go,” he said.

The study was funded by the US National Institutes of Health.

Image credit: iStock

Share Button

Health24.com | Flu shots for kids protect everybody, a US study shows

  •  In the USA, there is an issue of vaccine hesitance when it comes to children
  • When kids get the flu shot, there is, however, a general reduction in flu hospitalisations
  • An expert described children as ‘magnifying influenza’

When elementary school students get their annual flu shot, everyone benefits, a new study shows.

An increased vaccination rate among grade-schoolers in California was associated with a decrease in flu hospitalisations for people in every other age bracket, researchers report.

The results come as no surprise to public health experts, given children’s well-earned reputation as a major vector for the spread of viral diseases.

“It basically correlates with everything we know about public health, about vaccination, and about children and children’s impact on spreading viral illness throughout a community,” said Dr Eric Cioe-Pena, director of global health for Northwell Health in New Hyde Park, New York.

Vaccine hesitance

However, the study does highlight the continuing need to convince reluctant parents of the importance of getting their kids an annual flu shot, Cioe-Pena added.

“We have an issue of vaccine hesitance in [the United States] when it comes to children,” said Cioe-Pena. “To me, if you don’t get to the root cause of the hesitance, it probably won’t have much of an impact.”

For this study, researchers led by Jade Benjamin-Chung, from the University of California, Berkeley, tracked a city-wide school flu vaccine program in Oakland, California, and compared its success to rates of flu-associated hospitalisations.

After four years, the programme had improved vaccination coverage by 11% among children attending more than 95 preschools and elementary schools in Oakland, the researchers reported.

The increased vaccination rate was associated with 37 fewer flu-related hospitalisations per 100 000 people among all other people in the community – children aged four and younger as well as people aged 13 and older.

Fewer school absences

There were also 160 fewer influenza hospitalisations per 100 000 among people aged 65 and older, the results showed.

The elementary school children also benefited; researchers observed a decrease in illness-related school absences during the flu season.

The findings were published online on 18 August in the journal PLOS Medicine.

“We know that children magnify influenza,” said Dr Amesh Adalja, a senior scholar with the Johns Hopkins Center for Health Security in Baltimore. “Trying to increase children’s vaccination rates can be expected to have a cascading impact on the flu season. Making it easy for children to get vaccinated is one way to improve our ability to deal with influenza.”

Children tend to benefit more from the flu vaccine, because their immune systems are fresher and more responsive, Adalja added.

Congregational settings

“In younger people, the vaccine induces more antibodies than in individuals 70 years or older,” Adalja explained. “Older people’s immune systems do not respond to the vaccine as well as a younger individual does. That’s why we use high-dose vaccines with the elderly population.”

Given these results, it might make sense to promote flu shots for children as much as they are promoted for the elderly and health care workers, said Dr Waleed Javaid, director of infection prevention and control at Mount Sinai Downtown in New York City.

“When we can enhance our protection of any aspect of society where we have congregational settings and people are going to mingle with each other – like [the] military or hospitals or schools – that protects society in general,” Javaid said.

Adalja agreed.

“Our goal in the United States is to vaccinate everybody above the age of six months with influenza vaccine. That should still be the goal,” Adalja said. “If you’re trying to prioritise within that group, then children should be a major priority group to be vaccinated because they do drive it, but I do think you also have to vaccinate the vulnerable – the elderly and people with other medical conditions. They have to be a priority group as well.”

Image credit: iStock

Share Button

Girls Aloud singer Sarah Harding diagnosed with breast cancer

The 38-year-old star says she doing her best to stay positive after the “devastating” diagnosis.

Share Button

Spreadsheet error led to Edinburgh hospital opening delay

A new report reveals the catalogue of mistakes that left an Edinburgh children’s hospital unusable.

Share Button

Oral sex linked to vaginal condition bacterial vaginosis

Researchers explored what effect mouth bacteria have on microbes that live and grow in the vagina.

Share Button

Hydroxychloroquine plus azithromycin increases heart risk, finds global study

The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM. This network study, led by the Observational Health Data Sciences and Informatics community, was recently published in Lancet Rheumatology.

OHDSI has established an international network of researchers and observational health databases with a central coordinating center housed at the Department of Biomedical Informatics at Columbia University.

In patients with rheumatoid arthritis, HCQ treatment in the short term (30 days) was found to not carry excess risk of complications associated with its use, but HCQ treatment in the long term had a 65% relative increase in cardiovascular-related mortality, compared to sulfasalazine.

HCQ + AZM had a cardiovascular mortality risk that was more than twice (2.19) as high as the comparative treatment even in the short term based on findings from more than 320,000 users of that combination therapy. This treatment also produced a 15-20% increased rate of angina/chest pain and heart failure.

This study, first published on MedRxiv, has already made significant impacts in the healthcare community. On April 23, the European Medicines Agency (EMA) cited the study in a warning about the risk of serious side effects with chloroquine and hydroxychloroquine. In July, the EMA again highlighted the study, among other efforts within the OHDSI community, in its eighth revision of The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology.

This is the first published study to be generated from the OHDSI COVID Study-a-thon, a global effort in March to set the foundation for OHDSI efforts to design and execute network observational studies around characterization, patient-level prediction and population-level effect estimation to inform decision-making around the global pandemic. Multiple studies, several of which are highlighted later, have been posted to MedRxiv and are currently under peer review.

HCQ, a drug commonly used in the treatment of malaria, lupus and rheumatoid arthritis (RA), gained early attention during the pandemic as a potential COVID-19 treatment. The short-term (<30 days) safety profile did not identify excess risk in any of 16 severe adverse events as compared to a similar RA drug, sulfasalazine (SSZ). Long-term HCQ therapy was associated with a 65% increase in cardiovascular mortality as compared to SSZ.

“Hydroxychloroquine, both alone and in combination with azithromycin, gained strong consideration as a potential COVID treatment without a large-scale study of its overall safety profile,” said Daniel Prieto-Alhambra, PhD, co-senior author on this study. “We had access to an unprecedented amount of data on this drug, and we were relieved to find no worrying side effects in the short-term use of hydroxychloroquine. However, when prescribed in combination with azithromycin, it may induce heart failure and cardiovascular mortality and we would urge caution in using the two together.”

This study examined more than 950,000 HCQ users through deidentified electronic health records and administrative claims data over a 20-year period. Records were collected from 14 different databases spanning six nations (Germany, Japan, Netherlands, Spain, United Kingdom, United States) and then mapped to the OMOP Common Data Model to generate this large-scale analysis.

“At medical school we were taught to ‘first do no harm’ and to me, our study focuses on this core belief of modern medicine,” said Jennifer Lane, MD, who served as co-lead author on this study along with Jamie Weaver. “OHDSI has the power to investigate this question in a very thorough way and to go through rigorous steps. We are looking at patients from the general population, which is why it is so important to look at data from multiple countries. There are reasons why you may get bias from one data source, but if we find a signal in the Netherlands, and we find it in Spain, and we find it in the U.S., then we know we have something.”

The study was developed and executed by the OHDSI (Observational Health Data Sciences and Informatics) community, a multi-stakeholder, interdisciplinary collaborative to bring out the value of health data through large-scale analytics. All solutions are open-source, and links to the study protocol, code and results are posted at the bottom of this release.

“It required a global effort to generate this level of reproducible, reliable real-world evidence to inform decision-making around COVID treatment,” said Patrick Ryan, PhD, co-senior author on this study. “Our community collaborated for years to develop the high-level analytics which set the course for these studies. Standardizing data for nearly 1,000,000 patients on hydroxychloroquine provides confidence in these findings, and we are pleased to see that this study has already helped make a positive clinical impact as treatment options continue to be evaluated.”

Share Button

Effectiveness of cloth masks depends on type of covering

Months into the COVID-19 pandemic, wearing a mask while out in public has become the recommended practice. However, many still question the effectiveness of this.

To allay these doubts, Padmanabha Prasanna Simha, from the Indian Space Research Organisation, and Prasanna Simha Mohan Rao, from the Sri Jayadeva Institute of Cardiovascular Sciences and Research, experimentally visualized the flow fields of coughs under various common mouth covering scenarios. They present their findings in the journal Physics of Fluids, from AIP Publishing.

“If a person can reduce the extent of how much they contaminate the environment by mitigating the spread, it’s a far better situation for other healthy individuals who may enter places that have such contaminated areas,” Simha said.

Density and temperature are intricately related, and coughs tend to be warmer than their surrounding area. Tapping into this connection, Simha and Rao utilized a technique called schlieren imaging, which visualizes changes in density, to capture pictures of voluntary coughs from five test subjects. By tracking the motion of a cough over successive images, the team estimated velocity and spread of the expelled droplets.

Unsurprisingly, they found N95 masks to be the most effective at reducing the horizontal spread of a cough. The N95 masks reduced a cough’s initial velocity by up to a factor of 10 and limit its spread to between 0.1 and 0.25 meters.

An uncovered cough, in contrast, can travel up to 3 meters, but even a simple disposable mask can bring this all the way down to 0.5 meters.

“Even if a mask does not filter out all the particles, if we can prevent clouds of such particles from traveling very far, it’s better than not doing anything,” said Simha. “In situations where sophisticated masks are not available, any mask is better than no mask at all for the general public in slowing the spread of infection.”

Some of the other comparisons, however, were striking.

For example, using an elbow to cover up a cough is typically considered a good alternative in a pinch, which is contradictory to what the pair found. Unless covered by a sleeve, a bare arm cannot form the proper seal against the nose necessary to obstruct airflow. A cough is then able to leak through any openings and propagate in many directions.

Simha and Rao hope their findings will put to rest the argument that regular cloth masks are ineffective, but they emphasize that masks must continue to be used in conjunction with social distancing.

“Adequate distancing is something that must not be ignored, since masks are not foolproof,” Simha said.

Story Source:

Materials provided by American Institute of Physics. Note: Content may be edited for style and length.

Share Button

Accumulating extra genome copies may protect fly brain cells during aging

Scientists have discovered a novel anti-aging defence in the brain cells of adult fruit flies: producing extra copies of the genome, according to a new study published today in eLife.

The findings could help explain how the brain, which rarely produces new cells, is able to cope with the accumulation of cell damage over time and prevent excess cell loss during aging. They may also help scientists answer questions about human age-related brain diseases.

Most cells have two copies of each chromosome, one from each parent. This provides each cell with two complete copies of DNA, referred to as the genome. But some cells accumulate extra copies of chromosomes, although how and why they do this is not entirely clear. Some scientists have suggested that excess chromosomes might lead to age-related brain diseases.

“The brain of the fruit fly Drosophila melanogaster is an ideal model for studying age-related changes in the brain because the fly has a relatively short lifespan, its brain cells rarely multiply, and we have excellent tools for manipulating fly genetics,” says lead author Shyama Nandakumar, a doctoral student in the department of Molecular, Cellular, and Developmental Biology at the University of Michigan, Ann Arbor, US.

In the study, Nandakumar and colleagues examined adult fly brain cells and found that some accumulate extra copies of their genome, especially in parts of the brain responsible for vision — the region of the brain which shows more DNA damage with age.

Next, they subjected fly brain cells to oxidative stress or ultraviolet radiation, which damage DNA and can cause cell death. They found that this exposure increased the production of extra copies of chromosomes in the cells, and the cells were less likely to die as a result of the damage. “These data suggest that cells with extra copies of the genome are more resistant to cell death and may serve a beneficial or protective role in the aging brain,” Nandakumar explains.

Previous studies have found that patients with early stages of Alzheimer’s disease have extra chromosomes in their brain cells than people of the same age who do not have the condition. This has led scientists to question whether accumulating extra chromosomes leads to brain cell death and brain disease.

“Our study suggests that the production of extra copies of chromosomes might actually be a normal response to the accumulation of age-related damage in flies and may even help protect against cell death,” concludes senior author Laura Buttitta, Associate Professor of Molecular, Cellular and Developmental Biology at the University of Michigan. “Further studies are now needed to determine if this is also true in humans.”

Story Source:

Materials provided by eLife. Note: Content may be edited for style and length.

Share Button